4 leading Chinese lung cancer experts to discuss current research/clinical issues, in Mandarin – IASLC

Stephen V. Liu shared a post by IASLC on X, adding:

“Thanks to Drs. Chunxia Su, Xiuning Le, Jianming Ying, and Li Zhang – and to IASLC for their continued global focus on educational resources in many different languages and formats!”

Quoting IASLC’s post:

“Part of an ongoing series of podcasts in world languages, this episode brings together 4 leading Chinese lung cancer experts to discuss current research/clinical issues, in Mandarin. With Dr. Chunxia Su, Dr. Xiuning Le, Dr. Jianming Ying and Professor Li Zhang.”

Source: Stephen V. Liu/X and IASLC/X

Stephen V. Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.

As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.

Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered.”